Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Kidney Neoplasms 3Carcinoma, Renal Cell 3Leukemia 2Uveal Melanoma 1Thrombocytosis 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neurofibroma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Metastatic Gastrointestinal Carcinoid Tumor 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Head and Neck Neoplasms 1Glioma 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

AZD 6244 9trametinib 3mirdametinib 3Lovastatin 3Sirolimus 2Inhalation 2Everolimus 2Acetylcysteine 2tipifarnib 1thymoglobulin 1pirfenidone 1peginterferon alfa-2b 1omipalisib 1fludarabine 1cediranib 1binimetinib 1Vitamin D 1Vincristine 1Vinblastine 1Temozolomide 1Sunitinib 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1Photochemotherapy 1N-monoacetylcystine 1Methotrexate 1Melphalan 1Levetiracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurofibromatosis 1 × peginterferon alfa-2b × Clear all
NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Corewell Health West

Phase 2 Completed
9 enrolled 9 charts
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡